This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Enzo Life Sciences
other brands :
Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis
product type :
chemical
product name :
Anandamide
catalog :
BML-FA017-0005
quantity :
5 mg
citations: 10
Reference
Grimaldi C, Pisanti S, Laezza C, Malfitano A, Santoro A, Vitale M, et al. Anandamide inhibits adhesion and migration of breast cancer cells. Exp Cell Res. 2006;312:363-73 pubmed
Underdown N, Hiley C, Ford W. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br J Pharmacol. 2005;146:809-16 pubmed
Van Der Stelt M, Di Marzo V. Anandamide as an intracellular messenger regulating ion channel activity. Prostaglandins Other Lipid Mediat. 2005;77:111-22 pubmed
Hillard C, Jarrahian A. Accumulation of anandamide: evidence for cellular diversity. Neuropharmacology. 2005;48:1072-8 pubmed
Randall M. The cardiovascular actions of anandamide: more targets?. Br J Pharmacol. 2005;145:565-6 pubmed
Chen J, Han X, Xie X. Preferred conformations of endogenous cannabinoid ligand anandamide. Life Sci. 2005;76:2053-69 pubmed
Contassot E, Wilmotte R, Tenan M, Belkouch M, Schnuriger V, De Tribolet N, et al. Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1. J Neuropathol Exp Neurol. 2004;63:956-63 pubmed
Movsesyan V, Stoica B, Yakovlev A, Knoblach S, Lea P, Cernak I, et al. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways. Cell Death Differ. 2004;11:1121-32 pubmed
Joseph J, Niggemann B, Zaenker K, Entschladen F. Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother. 2004;53:723-8 pubmed
Sarker K, Maruyama I. Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell Mol Life Sci. 2003;60:1200-8 pubmed
product information
Product ID :
BML-FA017
Catalog Number :
BML-FA017-0005
Product Name :
Anandamide
Product Type :
Biochemical
Size :
5 mg
list of Pubmed id :
16343481, 16158067, 16099396, 15910883, 15834438, 15826873, 15453094, 15375383, 15034673, 12861385
Product Description :
Endogenous [1] ligand for the CB1 receptor (CB1: Ki=52nm; CB2: Ki=1930nm [2]) and TRPV1 (Ki=5.78µM [3,4]). Inhibits NF-κB activation through direct binding to IKKβ [5] and induces apoptosis independently of cannabinoid or vanilloid receptors [6]. Activates the MAP kinase (MAPK/ERK) signalling pathway [7].
ALTnames :
AEA, N-Arachidonoylethanolamine, (all-Z)-N-(2-Hydroxyethyl)-5,8,11,14-eicosatetraenamide
Purity :
≥98% (TLC)
Storage :
-80°C
company information
Enzo Life Sciences
5777 Hines Drive
Ann Arbor, MI 48108
info-us@enzolifesciences.
https://www.enzolifesciences.com
1-800-942-0430
headquarters: USA
Enzo Life Sciences, incorporating ALEXIS® Biochemicals and BIOMOL® International, offers a comprehensive panel of innovative life science reagents. Antibodies, enzymes, proteins, small molecule inhibitors, product libraries, and assay kits are available for research in Cancer, Cell Death, Epigenetics, Genomics, Immunology, Neuroscience, Signal Transduction, and Ubiquitin & Proteasomes, Enabling Discovery in Life Science(tm). Visit www.enzolifesciences.com.